The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of 0.25 mg/0.5 mL pens of the pharmaceutical product WEGOVY. The contract has a ceiling value of $3,634.12 and a performance period ending on January 3, 2025. This contract award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program. The contract does not have a set-aside designation.
Generated 4/3/25, 10:59 AM